Remove FDA Remove Medicine Remove Physicians
article thumbnail

Medical Devices Are Evolving Toward Specialized Solutions

MedCity News

However, one-size-fits-all solutions have disadvantages in medicine today. Current applications Today, there is an escalated appetite to address emerging procedures because they offer an opportunity for device makers – and physicians like me who are interested in cutting-edge technology – to influence new areas of medicine.

article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

Accelerated Approval was developed in 1992 in response to the HIV/AIDS crisis and has led to expedited drug and biologic approvals in several disease areas across the FDA. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. Do patients care? Do patients care?

Patients 200
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Takeda ulcerative colitis biologic receives FDA approval

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Takeda’s single-dose pre-filled pen for ENTYVIO ® (vedolizumab) as a treatment for the chronic inflammatory disease ulcerative colitis. FDA’s approval is based on the Phase III VISIBLE 1 study (SC UC Trial).

article thumbnail

“Game-changing” obesity drug over-promising?

World of DTC Marketing

. “Obesity is multifactorial, meaning many factors are involved and go from genetics, lifestyle, mental health issues (such as trauma) to medication side effects,” says Dr. Viana, Clinical Director Yale Medicine Metabolic Health & Weight Loss Program. Click to Tweet.

Insurance 271
article thumbnail

What is Biogen and can they repair their reputation?

World of DTC Marketing

Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. Biogen is in trouble.

Insurance 222
article thumbnail

Is DTC effective?

World of DTC Marketing

According to a study in the Journal for American Board of Family Medicine “respondents (76%) said they were likely to ask a health care provider about advertised drugs; 26% said they had already done so. The FDA can be myopic when researching how consumers view and react to DTC. Is TV the best channel?

article thumbnail

Vertex and CRISPR Therapeutics submit BLAs to FDA for exa-cel

Pharmaceutical Technology

Vertex Pharmaceuticals and CRISPR Therapeutics have completed the rolling submission of biologics licence applications (BLAs) to the US Food and Drug Administration (FDA) for exagamglogene autotemcel (exa-cel) to treat sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).